REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Martins Silva A, Correia de Sá J, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L.
Batista S, et al. Among authors: mendonca mt.
Neurol Sci. 2021 May;42(5):1995-2003. doi: 10.1007/s10072-020-04726-6. Epub 2020 Sep 30.
Neurol Sci. 2021.
PMID: 32997282
Free PMC article.